Results 201 to 210 of about 10,579 (219)

Islet Cell Antibodies and Viral Infections

Experimental and Clinical Endocrinology & Diabetes, 2009
The sera of 127 non-diabetic children after mumps-infection were investigated for the presence of islet cell antibodies and islet cell surface antibodies. The study also included 4 children who developed diabetes mellitus shortly after an active mumps vaccination.
A. Otten, Konrad Federlin, K. Helmke
openaire   +3 more sources

Immunoglobulins and Viral Antibodies in Psychiatric Patients

British Journal of Psychiatry, 1978
SummaryThe serum and CSF of 66 patients with functional psychoses were tested for immunoglobulins and antibodies to measles, HSV-1, CMV, and rubella viruses. Ten surgical and 80 neurological patients were controls. There were no significant findings in the serum, consistent with most previous studies. In the CSF 6 of 17 multiple admission schizophrenic
D P Van Kammen, W L Brannon, William T. Carpenter, E F Toorey, M R Peterson, Post Rm   +5 more
openaire   +3 more sources

Rubella Antibodies and Acute Viral Hepatitis

Scandinavian Journal of Infectious Diseases, 1977
High antibody titres against rubella and measles viruses have recently been associated with certain chronic disorders such as chronic active hepatitis and occasionally with acute hepatitis. The present study was designed to evaluate the frequency of this association with acute hepatitis.
K, Sloth, A, Vaheri, O, Laitinen, V, Faber, , CHAP   +4 more
openaire   +3 more sources

Antibody Response to Viral Antigens

1973
Publisher Summary This chapter focuses on humoral antibody response. It describes the general nature of viral antigens, what is being determined by seriological procedures applied to virus systems, the appraisal of such data for diagnostic and vaccine evaluation purposes, and the nature of the antibody response and some potential implications to ...
openaire   +3 more sources

Antibodies sustain viral control

Science, 2016
HIV-1 Therapy For many infected individuals, antiretroviral therapy (ART) means that an HIV-1 diagnosis is no longer a death sentence. But the virus persists in treated individuals, and complying with the intense drug regimen to keep virus loads down can be challenging for patients. Seeking an alternative, Byrareddy et al.
openaire   +2 more sources

An antibody to block viral fusion [PDF]

Science, 2016
HIV-1 Antibodies A small fraction of HIV-1–infected individuals develop broad and potent antibodies that bind the HIV-1 envelope protein (Env). These antibodies recognize a limited set of conserved epitopes on Env, such as Env's host receptor-binding site. Kong et al.
openaire   +1 more source

Antibody enhanced viral growth in macrophages

Immunology Letters, 1985
Antiviral antibody can promote viral entry into macrophages by pathways involving cellular receptors for the Fc portion of immunoglobulin or for complement components. Whether virus taken up through these routes is restricted or results in productive infection depends upon a balance between a number of variables. These include the virus strain and dose,
openaire   +3 more sources

Antibodies for the prevention and treatment of viral diseases

Antiviral Research, 2000
This paper reviews current use and evolving role of polyclonal and monoclonal antibody products for the prevention and treatment of viral diseases. Antibodies continue to be indicated for prophylaxis either prior to an anticipated exposure especially in situations of travel, or more commonly following an exposure.
openaire   +3 more sources

Antibody Affinity and Valence in Viral Neutralization

The Journal of Immunology, 1972
Abstract This work shows that viral neutralization appears to be a function not only of antibody concentration but also of affinity, valence, and possibly molecular configuration of antibody. When antibody molecules of similar valence are grouped, neutralization increases with increasing molecular affinity.
S E, Blank, G A, Leslie, L W, Clem
openaire   +2 more sources

Antibody-Dependent Enhancement of Viral Infectivity

1986
Publisher Summary This chapter surveys the historical background to the phenomenon of antibody-dependent enhancement (ADE) of viral infectivity and considers the two mechanisms that are known to exist. It updates the earlier review of Halstead that was concerned solely with enhancement mediated by cellular receptors for the Fc portion of ...
openaire   +3 more sources